Collaborative Fund Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.78M Buy
1,537
+308
+25% +$363K 0.96% 20
2026
Q2
$1.47M Buy
1,229
+245
+25% +$250K 0.86% 28
2026
Q1
$905K Buy
+984
New +$998K 0.56% 63

Other funds holding LLY

Collaborative Fund Advisors's LLY Position: Q3 2026 in Review

Collaborative Fund Advisors increased its Eli Lilly (LLY) stake by 25% in Q3 2026, buying an estimated $363K and bringing the position to 1,537 shares worth $1.78M. The position accounts for 0.96% of the portfolio, ranked #20.

Collaborative Fund Advisors first reported a position in LLY in Q1 2026 and has held it in 3 quarters since. 4,602 funds tracked by Wall St. Rank hold LLY as of Q3 2026.

  • Collaborative Fund Advisors held 1,537 shares of Eli Lilly worth $1.78M as of Q3 2026.
  • Collaborative Fund Advisors bought 308 Eli Lilly shares in Q3 2026, an estimated $363K.
  • Eli Lilly made up 0.96% of Collaborative Fund Advisors's portfolio in Q3 2026, its #20 holding.
  • Collaborative Fund Advisors first reported a position in Eli Lilly in Q1 2026 and has held it in 3 quarters since.
  • 4,602 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.

Based on Collaborative Fund Advisors's 13F filing for Q3 2026, filed 2 Nov 2026.